DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Condition: Lymphoma, Non-Hodgkin Intervention: Drug: DZD8586 Sponsor: Dizal Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials